MLKL Gene

📖 Wiki Page

gene1008 wordssynced 2026-04-02

MLKL Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">MLKL Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>MLKL</td>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>Mixed Lineage Kinase Domain-Like</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>16q23.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>83568</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q8TBX5</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000147854</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>RHIM domain-containing pseudo-kinase</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~54 kDa</td>
</tr>
<tr>
<td class="label">Domain</td>
<td>Location</td>
</tr>
<tr>
<td class="label">Four-Helix Bundle (4HB)</td>
<td>N-terminal (1-180)</td>
</tr>
<tr>
<td class="label">Intermediate Domain</td>
<td>(180-290)</td>
</tr>
<tr>
<td class="label">Pseudokinase Domain (KD)</td>
<td>C-terminal (290-480)</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Necrostatin-1</td>
<td>RIPK1 inhibitor</td>
</tr>
<tr>
<td class="label">GW39714</td>
<td>RIPK3 inhibitor</td>
</tr>
<tr>
<td class="label">Compound 18</td>
<td>MLKL direct inhibitor</td>
</tr>
<tr>
<td class="label">Z-VAD-FMK</td>
<td>Pan-caspase inhibitor</td>

...

MLKL Gene

Pathway Diagram

Mermaid diagram (expand to render)

Introduction

Mlkl Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

MLKL (Mixed Lineage Kinase Domain-Like) is a crucial effector protein in the necroptosis pathway, executing programmed necrotic cell death downstream of Receptor-Interacting Protein Kinase 3 (RIPK3). While originally identified as a pseudokinase due to its lack of canonical kinase activity, MLKL plays an essential role in executing necroptosis—a form of programmed cell death distinct from [apoptosis](/entities/apoptosis) that is characterized by membrane rupture and release of intracellular contents. This page covers the gene structure, protein function, disease associations, and therapeutic implications of MLKL in neurodegenerative diseases. [@wang2014]

Gene Information

Gene Structure

The MLKL gene consists of 10 exons spanning approximately 12 kb of genomic DNA. The gene encodes a protein with 480 amino acids containing an N-terminal four-helix bundle (4HB) domain and a C-terminal pseudokinase domain (KD). The pseudokinase domain retains the ability to bind ATP but lacks catalytic activity, functioning instead as a regulatory domain that interacts with RIPK3.

Isoforms

Multiple splice variants have been identified:

Isoform 1 (canonical): Full-length 480 amino acids
Isoform 2: Truncated variant lacking C-terminal domain

Protein Structure and Function

MLKL functions as the key executioner of necroptosis through a well-characterized molecular cascade:

Activation: In response to death receptor ligands (TNF-α, FasL, TRAIL), RIPK1 recruits and activates RIPK3

Phosphorylation: RIPK3 phosphorylates MLKL at Thr357 and Ser358 (human)

Oligomerization: Phosphorylated MLKL undergoes conformational change and forms oligomers

Membrane Translocation: MLKL oligomers translocate to the plasma membrane

Pore Formation: MLKL inserts into the membrane, forming necrotic pores (10-50 nm diameter)

Cell Lysis: Membrane rupture releases DAMPs (damage-associated molecular patterns)

Key Domains

Expression Pattern

MLKL is expressed in most human tissues with highest levels in:

Brain: [Cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), cerebellum, basal ganglia
Immune system: Lymphocytes, macrophages, dendritic cells
Cardiovascular: Heart, vascular endothelium
Gastrointestinal: Intestine, liver

In the brain, MLKL is expressed in:

[Neurons](/entities/neurons) (particularly cortical pyramidal neurons)
[Astrocytes](/entities/astrocytes)
[Microglia](/entities/microglia)
[Oligodendrocytes](/cell-types/oligodendrocytes)

Role in Neurodegeneration

Alzheimer's Disease

In Alzheimer's disease, MLKL-mediated necroptosis contributes to:

Amyloid-β induced neuronal death: [Aβ](/proteins/amyloid-beta) oligomers activate RIPK1/RIPK3/MLKL pathway
[Tau](/proteins/tau) pathology interaction: Hyperphosphorylated [tau](/proteins/tau) enhances necroptotic signaling
Neuroinflammation: Microglial necroptosis releases pro-inflammatory DAMPs
Synaptic loss: Necroptotic neurons release synaptic proteins, accelerating pathology

Key Evidence:

Elevated MLKL phosphorylation in AD brain tissue (postmortem studies)
Correlation between p-MLKL levels and disease severity
Genetic deletion of MLKL protects against Aβ toxicity in mouse models

Parkinson's Disease

In Parkinson's disease, MLKL is implicated in:

Dopaminergic neuron vulnerability: Selective susceptibility of SNpc neurons
[α-Synuclein](/proteins/alpha-synuclein) toxicity: Pathological α-synuclein activates necroptosis
Mitochondrial dysfunction: Complex I deficiency enhances MLKL activation
Neuroinflammation: Microglial necroptosis in PD brains

Key Evidence:

Increased p-MLKL in PD substantia nigra
RIPK1/MLKL activation in toxin-based PD models (MPTP, 6-OHDA)
Protective effects of MLKL knockout in experimental PD

ALS (Amyotrophic Lateral Sclerosis)

[TDP-43](/proteins/tdp-43) pathology triggers necroptotic pathways
Mutant SOD1 induces MLKL activation in motor neurons
Non-cell autonomous toxicity from astrocytic necroptosis

Huntington's Disease

Mutant [huntingtin](/proteins/huntingtin-protein) protein activates RIPK1/MLKL pathway
Contributes to striatal neuron degeneration

Therapeutic Targeting

MLKL Inhibitors

Therapeutic Strategies

Direct MLKL inhibition: Small molecules targeting MLKL oligomerization

RIPK3 blockade: Preventing MLKL phosphorylation

Combination therapy: MLKL inhibitors with existing neuroprotective agents

Challenges

[Blood-brain barrier](/entities/blood-brain-barrier) penetration
Specificity for neuronal vs immune cell necroptosis
Timing of intervention in disease progression

Animal Models

MLKL knockout mice: Viable and fertile, resistant to necroptotic cell death
Conditional knockouts: Neuron-specific and [microglia](/cell-types/microglia-neuroinflammation)-specific models available
Transgenic models: Expressing human MLKL mutants

Biomarkers

p-MLKL (Thr357): Detectable in CSF and blood
MLKL oligomers: Tissue biomarkers
[Necroptosis](/entities/necroptosis)-associated DAMPs: HMGB1, S100A9 in circulation

Research Directions

Developing brain-penetrant MLKL inhibitors
Biomarker validation for clinical trials
Combination approaches with anti-amyloid and anti-tau therapies
Understanding cell-type specific necroptosis mechanisms

Background

The study of Mlkl Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[NCBI Gene: MLKL](https://www.ncbi.nlm.nih.gov/gene/83568)
[UniProt: Q8TBX5](https://www.uniprot.org/uniprot/Q8TBX5)
[GeneCards: MLKL](https://www.genecards.org/cgi-bin/carddisp.pl?gene=MLKL)
[OMIM: MLKL](https://www.omim.org/entry/614396)

References

[Sun L, et al, (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/22265413/)

[Wang H, et al, (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/24709636/)

[Caccamo A, et al, (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/28232766/)

[Iannielli A, et al, (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29605867/)

[Qin D, et al, (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31034628/)

[Zhang S, et al, (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32857213/)

[Liu Y, et al, (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/34289456/)

[Wang Z, et al, (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/35691578/)

Pathway Diagram

The following diagram shows the key molecular relationships involving MLKL Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

MLKL Gene

MLKL Gene

MLKL Gene

Pathway Diagram

Introduction

Overview

Gene Information

Gene Structure

Isoforms

Protein Structure and Function

Key Domains

Expression Pattern

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

ALS (Amyotrophic Lateral Sclerosis)

Huntington's Disease

Therapeutic Targeting

MLKL Inhibitors

Therapeutic Strategies

Challenges

Animal Models

Biomarkers

Research Directions

Background

See Also

External Links

References

Pathway Diagram